Coppell Advisory Solutions LLC Bluebird Bio, Inc. Transaction History

Coppell Advisory Solutions LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $2,038 - $2,733	675 Added 50.0%	2,025 $28.5 Million
Q2 2023 Aug 17, 2023	BUY	$2.79 - $5.03 $3,766 - $6,790	1,350 New	1,350 $20.8 Million
Q1 2023 May 19, 2023	SELL	$3.14 - $8.22 $2,119 - $5,548	-675 Closed	0 $0
Q4 2022 May 19, 2023	BUY	$5.77 - $8.49 $3,894 - $5,730	675 New	675 $9.51 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Coppell Advisory Solutions LLC with notifications on news.